Lv1
40 积分 2021-08-15 加入
P4.11E.05 A Phase II, Randomized Trial of Trilaciclib Plus Chemotherapy and Tislelizumab as First-Line Treatment for Advanced SqNSCLC
4个月前
已关闭
P4.11E.05 A Phase II, Randomized Trial of Trilaciclib Plus Chemotherapy and Tislelizumab as First-Line Treatment for Advanced SqNSCLC
4个月前
已关闭
Evaluation of the efficacy and safety of a precise thymalfasin-regulated PRaG regimen for advanced refractory solid tumours: protocol for the open-label, prospective, multicentre study (PRaG5.0 study)
5个月前
已完结
Hydrocephalus: historical analysis and considerations for treatment
1年前
已完结
Meta-analysis of patent foramen ovale closure versus medical therapy for prevention of recurrent ischemic neurological events
2年前
已完结
Patent foramen ovale closure vs. medical therapy alone after cryptogenic stroke in China: A cost-effectiveness analysis
2年前
已完结
Correlation of Alberta Stroke Program Early Computed Tomography Score With Computed Tomography Perfusion Core in Large Vessel Occlusion in Delayed Time Windows
2年前
已完结
Young CSF restores oligodendrogenesis and memory in aged mice via Fgf17
2年前
已完结
Neuron-derived neuropeptide Y fine-tunes the splenic immune responses
3年前
已完结
10.1016/j.neuron.2022.01.010
3年前
已完结
皖公网安备34019202002308
